Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hair loss in men is common, treatable, but not curable.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Androgenetic alopecia in women needs more research and better management strategies.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Spironolactone can reduce hair growth in women with hirsutism.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Certain drugs that block specific enzymes can help treat prostate diseases.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Female hair loss linked to metabolic syndrome, not in males.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.